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813-3 Constrictive PericardiUs With Normal Pericardial 
Thickness on Examination of Hiatopathology 
Deeeak R. Talreia, William D. Edwards, Jae Oh, Henry Tazelaar, Gordon Danielson, 
Mayo Clinic, Rochester, Minnesota. 
Background: Increased pericardial thickness (PT) has been viewed as an essential diag- 
nostic feature for constrictive pericarditls (CP). While there are reports of clinically-dem- 
onstrated CP with normal PT by non-invasive imaging, the evaluation of PT by 
histopathology in CP has not been described. 
Methods: Among 143 pericardial specimens from patients who underwent pedcardiec- 
tomy for clinically- and/or surgically-proven CP at Mayo Clinic Rochester, 26 (18%) had 
normal thickness (that is, <= 2 mm). For these 26 patients, surgical pathology and the 
corresponding microscopic slides were examined for the presence of inflammation, calci- 
fication, and fibrosis. Medical records were reviewed to characterize preoperative fea- 
tures including clinical findings, computed tomography (CT) and radiographic imaging, 
echocardiography and cardiac catheterization. 
Results: The 26 patients ranged from 42 to 81 years old (mean, 58) with a striking male 
preponderance (73%). 
No patient had an entirely normal pericardium. Histopathologic abnormalities included 
fibrosis (85%), inflammation (54%), gross and/or microscopic calcification (35%), fibrin 
deposition (19%) and focal non-caseating granulomas (7%). 
Etiologies for CP included previous cardiac surgery (42%), chest irradiation (19%), 
postinfarctlon (7%), idiopathic (7%) and sarcoidosis, chest trauma, and acute viral peri- 
carditis in the remainder (25%). latrogenic disease was the most common cause of con- 
striction (61%). The most prevalent symptoms were lower extremity edema (88%), 
dyspnea (85%), and abdominal distention (77%). The most common physical findings 
were peripheral edema (85%), increased jugular venous distention (81%) with rapid Y 
descent (54%), hepatomegaly (54%), ascites (54%), and pericardial knock (38%). This 
was essentially no different for patients with CP and increased PT. 
Conclusions: PT is normal in 18% of patients with surgically-proven constrictive peri- 
carditis although histopathology is abnormal. When clinical or hemodynamic features 
indicate CP in patients with heart failure, pericardiectomy should not be denied because 
of normal PT demonstrated by noninvasive imaging. 
11:45 a.m. 
813-4 The Long-Term Follow-Up Results of Alcohol Septal 
Ablation for Symptomatic Hypertrophic ObstrucUve 
Cardiomyopathy: The Baylor Experience (1996-2001) 
Valerian L. Fernandes. Sherif F. Nagueh, Nasser M. Lakkis, Jennifer Franklin, Robed 
Roberts, William H. Spencer, III, Bay/or College of Medicine, Houston, Texas. 
Background: Alcohol Septal Ablation (ASA) is an accepted procedure for relief of outflow 
obstruction and symptoms of Hypertrophic Obstructive Cardiomyopathy (HOCM). How- 
ever, there is still a paucity of data on the long term outcome. Herein we report the long 
term follow-up from the Baylor College of Medicine HOCM Registry. 
Methods: 213 consecutive symptomatic pts (51.2 -+ 16.7 yrs, 122 men) who underwent 
ASA were followed up over 4 years. A mean of 1.35 ± 0.56 septals were injected with 3.0 
± 1.33 cc ethanol per patient. The peak CK post procedure was 1463 _+ 884 Units. 33 
patients (15%) needed a permanent pacemaker post procedure. 
Results: A successful procedure resulted in a significant improvement in symptoms, 
exercise tolerance and reduction of outflow gradient (table). The initial benefits were 
maintained at 1,2, 3 and 4 years post procedure. 24 patients needed a repeat procedure 
and 5 patients had a myotomy-myomectomy forpersistence of symptoms following ASA. 
9 deaths (2 procedural, 2 SCD, 5 noncardiac) were recorded during the follow-up. 
Conclusion: Alcohol Septal Ablation is an effective procedure with an acceptable risk for 
patients with symptomatic HOCM. The initial benefits are maintained long term over a 4 
year period. 
Alcohol Septal Ablation - Follow-up Indices 
Indices Baseline 3 month 1 year 2 year 3 year 4 year 
NYHAangina 2.1+0.7" 1.2_+0.4 1.2_+0.4 1.1_+0.4 1,1_+0.3 1.1_+0.3 
NYHA Heart Failure 2.8_+0.6* 1.5_+0.5 1.3_+0.5 1.2_+0.4 1.3+0.5 1.1_+0.3 
SeptalThickness(cm) 2.1±0.5" 1.6_+0.4 1.3_+0.3 1.2±0.3 1.2_+0.4 1.2+0.4 
Resting Gradient (mm Hg) 60± 38* 18± 28 ~ 19 3± 7 5+ 10 8-+ 14 
Provoked Gradient (mm 95-+ 56* 54-+ 66 42_+ 38 28_+ 36 21_+ 20 11_+ 19 
Hg) 
Treadmill duration (sec) 304_+ 199" 425_+202 451_+210 413_+223 403±216 405_+ 161 
Ejection Fraction (%) 75_+ 7* 72_+ 9 69_+ 10 67+ t0 64± 11 63-+ 14 
* p value < 0.001 by ANOVA 
Noon 
813-5 Triphasic Response to Alcohol Septal Ablation 
Danita M. Yeeroer, Michael H. Picard, Igor F. Palacios, Gus J. Vlahakes, Michael A. Fifer, 
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 
Background: Alcohol (EtOH) septal ablation (SA) is an alternative therapy in selected 
patients with hypertrophic obstructive cardiomyopathy. Acute septal wall motion abnor- 
mality followed by later left ventdcular outflow tract (LVOT) remodeling are described as 
mechanisms for early and late relief of LVOT gradient. We have observed that, despite 
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acute reduction in gradient in the cath lab, it may increase in the days after septal abla- 
tion. This study characterizes the course of LVOT gradient after SA. Methods: 17 
patients were assessed by echo at referral ('nine 1), immediate pre-ablation (Time 2), 
immediate post-ablation (Time 3), pre-discharge (Time 4) and at 3 months (Time 5). 
Results: Patients were grouped according to their pattern of LVOT gradient response: 
monophasic success (n=7), triphasic success (n=7) and failure (n=3). There was no dif- 
ference in LVOT gradient between the 2 success groups at post-procedure Time 3, but 
the LVOT gradient in the triphasic success group was significantly increased at time 4, 
and was not different from that of the failure group at this time point. Groups did not differ 
in age, baseline upper septal thickness, EtOH amount, percent of upper septum perfused 
by EtOH or peak CK. Conclusions: When a significant decrease in gradient is achieved 
during SA, predischarge elevation in gradient does not predict failure. This finding sup- 
ports the mechanisms of acute reversible stunning followed by later long-term LVOT 
remodeling in relief of gradient after SA. 
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1110-141 Clusters of Differential Gene Expression of Structural 
Proteins Between Failing and Nonfailing Hearts: 
Preliminary Insights From OIIgonucleotide Microarrays 
W.H. Wilson Tang, Fen-Lai Tan. Gary S. Francis, Christine S. Moraveo, Jianbo Li, 
Carolyn Apperson-Hansen, Patrick M. McCarthy, James B. Young, Meredith Bond, 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Backgrounc~ Simultaneous identification of differential gone expression of structural 
proteins in the failing heart using microarrey technique has not been reported. 
Method:. Alterations in gene expression were compared between 7 non-failing and 8 fail- 
ing hearts with idiopathic dilated cardiomyopathy using high-density oligonucleotide 
microarrays (Hu-6800, Affymetrix Inc, CA) according to conservative criteria developed 
by our group (Tan et al). 53 known myocardial structural protein components were identi- 
fied and classified into clusters according to their known functional roles: 1) contractile 
proteins; 2) sarcomeric proteins; 3) cytoskeletai proteins; 4) membrane-associated pro- 
teins (MAP); 5) intercalated disc-associated proteins (IDAP); 6) extracellular matrix 
(ECM) proteins. 
Results: Of the 53 structural protein components identified, gene expression in 20 (38%) 
were found to be significantly different between failing and non-failing heads. We 
observed a consistent trend of altered gene expression in clusters of contractile proteins 
(down 1.5-fold in *x-actin, myosin light polypeptide 2 & 3, c~-tropomyosin, troponin T1), 
clusters of IMAPs (up 1.8-fold in connexin-43) and clusters of ECM proteins (up 1.5- to 5- 
fold in collagen, fibronectin, fibromodullin, lumican). On the other hand, gene expression 
of MAPs, sarcomeric and cytoskeletal proteins varied widely within their clusters, but sig- 
nificant changes were observed in c¢l-actinin (down 3.6-fold), c~l-tubulin (down 1.7-fold), 
~lb-tubulin (up 1.6-fold), ~2-tubulin (down 1.5-fold), pinin (up 1.8-fold) and c~-spectrin (up 
1.5-fold). Discrepancies in gene expression of some MAP/sarcomeric proteins between 
our study and published reports may warrant further investigation. 
Conclusion: Microarray technology provides an alternative strategy whereby numerous 
myocardial genes can be studied in a simultaneous manner. Clusters of gene expression 
of structural proteins can be explored according to their functional domains, with genes 
that control contractile function being consistently downregulated whereas genes associ- 
ated with structural integrity have a more heterogeneous pattern of expression. 
1110-142 Transmyocardial Gradient of Proinflammatory 
Cytokines in Patients With Decompensated Idiopathic 
Dilated Cardiomyopathy 
Hvuk-Jae Chano. Joon-Han Shin, So-Yeon Choi, Gyo-Seung Hwang, Myeong-Ho Yoon, 
Han-Soo Kim, Seung-Jea Tahk, Hae-Sim Park, Byung-il W. Choi, Ajou University School 
of Medicine, Suwon, South Korea. 
Background: Proinflammatory cytokines such as tumor necrosis factor alpha(TNFa) and 
intedeukin-6(IL-6) have been recently identified as contributors to the syndrome of 
chronic heart failure. However, the origin of these cytokines in heart failure remains 
unclear. Therefore, we analyzed concentrations of TNFa, IL-6 and their cognitive recep- 
tors in patients with recently(<1 month) decompensated heart failure in peripheral 
vein(PV) and coronary sinus(CS) simultaneously. 
Method: The study group included 24 patients(18 males) with mean age 59±8 years and 
ejection fraction of 29~16%. NYHA functional class were I: 4, II: 8, II1:2 and IV: 10 during 
the episode of decompensation. Blood sampling for TNFa, IL-6 and TNFa recep- 
tor(TNFaR) 1, 2 was collected from CS and PV to measure the difference as a part of 
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right heart catheterization. 
Results: TNFa and IL-6 were detected in 8 and 6 patients in CS respectively with 
absence in PV. IL-6 and TNFaR1, 2 level in PV was significantly correlated with that of 
CS(r=O.92, 1.0, t .0:p<O.001). The level of IL-6 and TNFaR1, 2 in CS have positive corre- 
lations with the sevedty of decompensetion(r=0.47, 0.49, 0.52:p<0.001), along with 
trans-myocardial gradient of IL-6 (r=0.58: p=0.01). 
Conclusion: The magnitude of a trans-myocardial gradient of cytokines depends on the 
sevedty of heart failure decompensation and therefore, increased plasma level of cytok- 
ines in heart failure might be the result of myocardial production. 
Mean±SEM, "13<0.05 compared to peripheral vein. 
(pg/ml) Peripheral vein Coronary sinus 
TNFa 0.4±0.2 1.5±0.3" 
TNFaR 1 t 717.2±216.3 1788.4±229.2* 
TNFaR2 3226.6±411.1 3347.1±420.5" 
IL-6 2.2±1 .O 5.44±1.4* 
1110-143 Limited Disstollc Response to Afterload in Mice 
Marc D. Feldman. Rebecca Blackwood, Danny Escobedo, Gregory L. Freeman, 
University of Texas Health Science Center, San Antonio, Texas. 
Background: The passive diastolic pressure-volume relationship of the left ventricle (LV) 
is nonlinear. Therefore, use of preloed reserve should move the end-diastolic (ED) work- 
ing point to a less compliant portion of the filling curve. Whether this occurs in mice, 
where exceedingly high heart rates diminish time for diastolic filling, is unknown. Accord- 
ingly, we assessed diastolic properties in hearts of open chest mice in response to sus- 
tained afterload. 
Methods: Mice (C57B, n = 6) were sedated, intubated, and via a sternotomy had a dual 
frequency pressure sensitive conductance catheter placed into the LV via the apex. A 
flow probe was placed around the thoracic aorta, Baseline LV pressure-volume relation- 
ships were recorded at steady state and during occlusion of the infedor vans cava. The 
heads were exposed to sustained aortic occlusion for 7 minutes and recordings were 
repeated. LVED pressure and volume, Tau, and chamber compliance (dP/dV) were 
determined. 
Results: As shown in the Table, aftedoad augmentation led to an increase in maximum 
pressure (Pmax) and LVEDV, but Tau, LVEDP and dP/dV did not change. 
Conclusions: Although afterload stress caused an increase in LVEDV, there was no 
attendant rise in LVEDP, indicating that the ventricles are operating on the fiat portion of 
the PV curve. At the high operating heart rates of mice, short diastolic filing pedods pre- 
clude LV filling sufficient o raise LVEDP. 
* p < 0.05 Baseline vs. Afterload 
HR Pmax LVEDV LVEDP Tau dP/dV 
(bpm) (mm Hg) (ul) (me Hg) (msec) (1/ul) 
Baseline 522 +/- 26 91 +/- 6 28 +/- 8 5 +/- 1 11 +/- 2 .053 +/- .017 
Aftadoad 470+/-36 119+/-2" 34+/-12" 4+/-2 16+/-7 .077+/-.066 
1110-144 Dynamic Expressions of eNOS, iNOS, and TNF-a in 
Canine Myocardium In Response to Pacing-Induced 
Dilated Cardiomyopathy 
Xinqiang Han, Lazaroa A. Nikotaidis. Carol Stolarski, Teresa Hentosz, Richard P. 
Shannon, A//egheny General Hospital, Pittsburgh, Pennsylvania. 
Background: Nitdc oxide (NO) and tumor necrosis factor ~ (TNF-(x) have been impli- 
cated in the pathogenesis of dilated cardiomyopathy. Whether and to what extend the 
failing head of large mammals expresses these cytokines in the absence of inflammation 
is unclear. 
Methods: We investigated the expressions of the constitutive ndothelial nitric oxide 
synthese (eNOS), the inducible NOS (iNOS), and TNF-c¢ in adult dogs under control con- 
ditions (conscious but chronically instrumented), following pacing-induced heart failure, 
and recovery from left ventdcular failure using immunohistochemical (IHC) staining tech- 
nique and Western blotting analysis. 
Results: In control myocardium, prominent eNOS staining was seen in endothelium of 
blood vessels of varying sizes within the myocardium, with weak but positive staining in 
the myocardium. No IHC signal was detected {or either iNOS or TNF-~ in the control 
hearts. Following pacing for 22 to 36 days when hemodynamically significant heart fail- 
ure developed (LVdP/dt, C: 2670¢61, CHF: 1298+89; LVEDP, C: 14±1, CHF: 34±2; H R, 
C: 80-J:5, CHF: 121i-6; n=6) there was a marked decrease in the eNOS staining while 
both iNOS and TNF-~ were detectable in the myocardial cytoplasm (n=5), as compared 
to controls (n=3). In four additional dogs, a moderate increase in eNOS and a concomi- 
tant decrease in iNOS and TNF-(x were observed one week after the pacing was 
stopped. Western blotting experiments confirmed the decrease in eNOS (140kd) and 
increase in TNF-c~ (51kd) protein levels in the myocardium of heart failure dogs. Further 
analysis using densitometry showed a 74% decrease in eNOS and 250% increase in 
TNF-(x. 
Conclusions: Our results suggest that loss of cardiac eNOS protection and emerging 
cytotoxic influence from increased myocardial TNF-c~ and iNOS expressions may be 
pathogenic in the development of dilated cardiomyopathy and congestive heart failure. 
The influence of these cytokines is reversible following cessation of pacing and corre- 
lates with hemodynamic recovery. 
JACC March 6, 2002 
1110-145 Analysis of Gene Expression During Induction and 
Regression of Cardiac Hypertrophy Using cDNA 
Microarrsy Technology 
Mveono-Chaq Cho. Hainan Piao, Jin-Sook Kwon, Tae-Jin Youn, Dong-Woon Kim, 
Young-Gyu Kim, Dong-Kwon Yang, Woo-Jin Park, Chungbuk National University 
Hospital, Cheongju~ South Korea, Kwangju Institute of Science and Technology, 
Kwangju, South Korea. 
Background; Recent advances in the production of cDNA micrcarrays have made it possi- 
ble to analyze gene expression of tens of thousands of genes simultaneously. We compared 
gene expression profiling in the rat models of cardiac hypedrophy-regression using cDNA 
microarrays in order to evaluate whether the altered gene expression during regression is a 
simple reversal of the hypertrophy induction program or the activation of a separate tran- 
scdptional program. 
Methods; Pressurs-ovedoad left ventdcular hypertrophy (LVH) was generated by transverse 
aortic constdction (TAC) and regression of LVH was induced by the elimination of pressure 
gradient (untying) at 2 weeks after TAC. 33p-labeled cDNAs prepared from total RNA 
extracted from LV samples before and after TAC and at days 1, 3, and 7 after untying were 
hybddized to Rat GeneFilters Microarrays (GF300 and GF301, Research Genetics, USA). 
Results; Of 10,330 genes initially screened, 83 known genes and 1,060 uncharectedzed 
expressed sequence tags (ESTs) had a level of expression 2 times or more in response to 
pressure ovedoeding. Among them, transcdption level of 269, 50 and 8 genes was continu- 
ously increased at days 1,3 and 7 after untying, respectively. Interestingly, gene expression 
of PLC4P4 and 11 ESTs was abruptly declined after induction of regression and maintained 
up to 3 days after untying but expression of 6 genes including PLCS-4 was normalized at 
day 7. In contrast, transcription level of 132 genes (16 known genes, 116 ESTs) was signifi- 
cantly declined after induction of prsssure-overloed LVH. One day after untying, expression 
of 40 ESTs were upregulated but 35 genes including 16 known genes showed depressed 
expression up to 7 days after untying. 
Conclusion; This study identified both known and novel genes whose expression is affected 
at different stages of cardiac hypertrophy and regression and demonstrates the applicability 
of cDNA microarray technology for identification of novel candidate genes. 
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1111-137 Impact of Underlying Heart Disssse on Success of 
Resynchronization in Severe Heart Failure 
Barbara Lamo. Johannes Heintze, Bert Hansky, Leon Krater, Lcthar Faber, Frank 
Warzok, Dieter Horstkotte, Reiner Koerfer, Juergen Vogt, Heart Center North Rhine- 
Westphalia, Bad Oeynhausen, Germany. 
Severe heart failure in coronary artery disease (CAD) is mainly caused by large myocar- 
dial scars and left ventdcular (LV) remodeling, in dilated cardiomyopathy (DCM) by pro- 
gressive diffuse myocardial fibrosis. The odgin of left bundle branch block (LBBB) in both 
entities is different: in DCM diffuse conduction delay with typical LBBB, in CAD central 
LBBB and often arbodsation. Whether these pathophysioiogical differences result in a 
different outcome in resynchronisation therapy (RT) is not known. 
We analysed the 161 consecutive pts. (mean age 61 years (y), (93 DCM, 56 CAD, 12 
other) who received RT with respect to the underlying heart disease. Mean follow-up 
(FU) was 9,9 months (m) (1-38). We found significant differences (p<0.05, unpaired t- 
test) between in LVEDD (83.7±11 versus 77.7±10 me) and VO2AT (11.3±2.5 versus 
10.1±2.4 ml/kg/min. NYHA class, VO2 peak, 6 rain walk, quality of life (Minnesota), EF 
and QRS did not differ. During FU at 3, 6 and 12 m DCM pts. had an ongoing improve- 
ment of all measured parameters. In contrast he CAD pts. improved only during the first 
3 m and then stayed stable. (Fig. 1). 
These data of a large patient cohort show for the first time, that pts. with CAD seem to 
respond less to RT than pts. with DCM during mid term FU. This is probably due to a 
more advanced scaring of the myocardium in CAD and a different pattern of asynchroy. 
Special indicators of RT-response for CAD pts. have not been identified yet, but will be 
very important. 
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